Home > Press > The Casiraghi Group, located at the University of Manchester's NanoScience and Spectroscopy Laboratory, use Raman in the study of graphene
The Renishaw inVia Raman confocal Raman microscope system |
Abstract:
Renishaw, a world leader in metrology and spectroscopy technologies, reports on the use of Raman spectroscopy in the study of graphene by the Casiraghi Group located at the University of Manchester's Nanoscience and Spectroscopy Laboratory.
Dr Cinzia Casiraghi is a Reader in Graphene and Carbon Nanostructures, in the School of Chemistry, at the University of Manchester, UK. She runs a research group, the Casiraghi Group, which uses Raman spectroscopy to derive quantitative information on the properties and structure of carbon nanostructures. Examples include measuring the diameter of carbon nanotubes, the width of graphene nanoribbons and the amount, and type, of defects in graphene. The Group also studies the fundamentals involved in the Raman scattering process of carbon nanomaterials. Although the Raman spectrum of graphite has been known since the 1970s, the Raman scattering process in sp2-bonded carbon nanostructures is still not completely understood. The group is engaged in activities which range from the production of graphene (and other 2D materials) to the fabrication of flexible devices made of graphene inks. Here, Raman is used as an important tool to characterise the material and possible changes introduced during the fabrication of devices. Her group works closely with the National Graphene Institute (NGI), a new £61M facility at the University of Manchester.
Commenting on her use of a Renishaw inVia confocal Raman microscope system, Dr Casiraghi says, "inVia is a user-friendly and sensitive Raman spectrometer which can be equipped with both mapping and multi-wavelength capabilities. Both are very useful in the study of graphene and other carbon nanostructures. Mapping allows us to collect the Raman signal from a particular area of the sample, while multi-wavelength Raman spectroscopy enables us to study if, and how, the Raman spectrum changes when the material is excited at different energies. This is very important for graphene and sp2-bonded carbon nanostructures because there are certain peaks that change in position when the excitation energy is changed. This behaviour is correlated to the properties of the material. We recently purchased a Renishaw inVia system for the new National Graphene Institute (NGI). The instrument is equipped with several lasers lines, ranging from visible to near-UV (325 nm), and has a Raman mapping capability. It is very easy to change the wavelength. The UV capability is also very attractive, as the 325 nm line can be easily added to the visible lines, so it does not require buying two separate instruments. The instrument will be used for metrology studies and to set standards for graphene, in collaboration with the National Physical Laboratory (NPL)."
Continuing to describe her work, Dr Casiraghi said that the Casiraghi Group recently used the new Renishaw inVia to demonstrate the use of Raman spectroscopy as a non-destructive and rapid technique for probing the van der Waals forces between two atomically thin crystals (K-G Zhou et al, ACS Nano, 2014, 8 (10), pp 9914-9924). By performing Raman mapping on several types of heterostructures, they showed that information on the quality of the interface can be derived by looking at the changes in positions of the Raman peaks of the transition metal dichalcogenide crystal.
For further details of Renishaw's inVia Raman system and other spectroscopy solutions, please visit www.renishaw.com/raman.
####
About Renishaw
Renishaw is a world leading engineering technologies company, supplying products used for applications as diverse as jet engine and wind turbine manufacture, through to dentistry and brain surgery. It employs over 3,700 people globally, some 2,400 of which are located at its 15 sites in the UK, plus over 1,300 staff located in the 32 countries where it has wholly owned subsidiary operations.
For the year ended June 2014 Renishaw recorded sales of £355.5 million of which 93% was due to exports. The company's largest markets are the USA, China, Germany and Japan.
The Company's success has been recognised with numerous international awards, including seventeen Queen's Awards recognising achievements in technology, export and innovation. Renishaw received a Queen's Award for Enterprise 2014, in the Innovations category, for the continuous development of the inVia confocal Raman microscope.
For more information, please click here
Contacts:
Renishaw plc
Old Town
Wotton-under-Edge
Gloucestershire GL12 7DW UK
T +44 (0)1453 523968
F +44 (0)1453 523901
www.renishaw.com/raman
Talking Science Limited
39 de Bohun Court
Saffron Walden
Essex CB10 2BA UK
T +44(0)1799 521881
M +44(0)7843 012997
http://www.talking-science.com/
Copyright © Renishaw
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
Imaging
Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Graphene/ Graphite
Breakthrough in proton barrier films using pore-free graphene oxide: Kumamoto University researchers achieve new milestone in advanced coating technologies September 13th, 2024
Discoveries
Breaking carbon–hydrogen bonds to make complex molecules November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Tools
Turning up the signal November 8th, 2024
Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024
Faster than one pixel at a time – new imaging method for neutral atomic beam microscopes developed by Swansea researchers August 16th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||